Article citationsMore>>

H. Asahina, K. Yamazaki, I. Kinoshita, et al., “A Phase II Trial of Gefitinib as First-Line Therapy for Advanced Nonsmall Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations,” British Journal of Cancer, Vol. 95, No. 8, 2006, pp. 998-1004. doi:10.1038/sj.bjc.6603393

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top